Congressional researchers are laying out the scope and limitations of the Trump administration’s marijuana rescheduling action—explaining that while certified patients who possess medical cannabis from state-licensed dispensaries now have certain protections, the industry as a whole isn’t “immediately” considered to be in “full compliance” with federal law, particularly as it concerns recreational products. In a…...
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
